John Arthur
Concepts (317)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Proteomics | 23 | 2019 | 343 | 3.870 |
Why?
| Acute Kidney Injury | 14 | 2023 | 403 | 3.070 |
Why?
| Renal Insufficiency, Chronic | 9 | 2024 | 182 | 2.560 |
Why?
| Glomerulonephritis, Membranous | 6 | 2023 | 37 | 1.790 |
Why?
| Electrophoresis, Gel, Two-Dimensional | 18 | 2010 | 55 | 1.500 |
Why?
| Kidney | 10 | 2020 | 820 | 1.370 |
Why?
| Lupus Nephritis | 5 | 2023 | 19 | 1.130 |
Why?
| Proteinuria | 5 | 2007 | 52 | 1.080 |
Why?
| Autoantibodies | 3 | 2023 | 132 | 0.870 |
Why?
| Kidney Diseases | 3 | 2019 | 293 | 0.870 |
Why?
| Glomerulonephritis | 2 | 2019 | 29 | 0.800 |
Why?
| Proteins | 5 | 2010 | 376 | 0.760 |
Why?
| Kidney Glomerulus | 8 | 2019 | 61 | 0.720 |
Why?
| Proteome | 3 | 2019 | 178 | 0.700 |
Why?
| Uremia | 1 | 2019 | 16 | 0.690 |
Why?
| Ruminococcus | 1 | 2019 | 9 | 0.690 |
Why?
| Urea | 1 | 2019 | 83 | 0.680 |
Why?
| Cecum | 1 | 2019 | 72 | 0.670 |
Why?
| Starch | 1 | 2019 | 33 | 0.670 |
Why?
| Glomerular Filtration Rate | 3 | 2015 | 138 | 0.650 |
Why?
| Predictive Value of Tests | 11 | 2018 | 1048 | 0.630 |
Why?
| Hypertension | 4 | 2020 | 563 | 0.630 |
Why?
| Bacteria | 2 | 2020 | 258 | 0.620 |
Why?
| Diabetic Nephropathies | 4 | 2015 | 77 | 0.620 |
Why?
| Intestines | 1 | 2019 | 204 | 0.600 |
Why?
| Bacterial Proteins | 2 | 2019 | 454 | 0.570 |
Why?
| Renin-Angiotensin System | 6 | 2021 | 64 | 0.560 |
Why?
| Humans | 50 | 2024 | 54246 | 0.540 |
Why?
| Prognosis | 8 | 2023 | 2118 | 0.540 |
Why?
| Glomerulosclerosis, Focal Segmental | 3 | 2014 | 17 | 0.520 |
Why?
| Interleukin-18 | 2 | 2015 | 19 | 0.510 |
Why?
| Disease Progression | 7 | 2020 | 913 | 0.480 |
Why?
| Renal Replacement Therapy | 2 | 2023 | 45 | 0.470 |
Why?
| Benzazepines | 2 | 2011 | 20 | 0.470 |
Why?
| Hyponatremia | 2 | 2011 | 15 | 0.470 |
Why?
| Animals | 27 | 2020 | 14385 | 0.450 |
Why?
| Membrane Glycoproteins | 2 | 2015 | 269 | 0.450 |
Why?
| Rats | 13 | 2019 | 3415 | 0.420 |
Why?
| Podocytes | 4 | 2014 | 24 | 0.420 |
Why?
| Angiotensin II | 4 | 2021 | 166 | 0.410 |
Why?
| Male | 32 | 2023 | 27312 | 0.410 |
Why?
| Diabetes Mellitus | 1 | 2015 | 307 | 0.410 |
Why?
| Cardiac Surgical Procedures | 2 | 2013 | 318 | 0.390 |
Why?
| Azotemia | 1 | 2010 | 2 | 0.380 |
Why?
| Kidney Tubular Necrosis, Acute | 1 | 2010 | 10 | 0.380 |
Why?
| Nephrology | 2 | 2022 | 17 | 0.370 |
Why?
| Inappropriate ADH Syndrome | 1 | 2010 | 4 | 0.370 |
Why?
| Angiotensinogen | 3 | 2013 | 12 | 0.350 |
Why?
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 10 | 2013 | 79 | 0.340 |
Why?
| Angiotensin I | 4 | 2014 | 15 | 0.340 |
Why?
| Creatinine | 6 | 2018 | 169 | 0.340 |
Why?
| Sodium | 3 | 2015 | 102 | 0.340 |
Why?
| Peptidyl-Dipeptidase A | 3 | 2021 | 24 | 0.330 |
Why?
| Female | 21 | 2023 | 28418 | 0.310 |
Why?
| Reproducibility of Results | 5 | 2010 | 1304 | 0.300 |
Why?
| Rats, Sprague-Dawley | 7 | 2019 | 1663 | 0.300 |
Why?
| Kidney Cortex | 2 | 2006 | 38 | 0.290 |
Why?
| Mass Spectrometry | 8 | 2023 | 313 | 0.290 |
Why?
| Myocardium | 2 | 2006 | 441 | 0.280 |
Why?
| Middle Aged | 15 | 2023 | 13070 | 0.280 |
Why?
| Urine | 2 | 2003 | 35 | 0.280 |
Why?
| Sea Lions | 2 | 2015 | 2 | 0.270 |
Why?
| Kainic Acid | 2 | 2015 | 33 | 0.270 |
Why?
| Immunoglobulin G | 3 | 2023 | 226 | 0.270 |
Why?
| Aged | 12 | 2020 | 10041 | 0.250 |
Why?
| Furosemide | 2 | 2015 | 9 | 0.250 |
Why?
| Diuretics | 2 | 2015 | 28 | 0.250 |
Why?
| Severity of Illness Index | 5 | 2015 | 1084 | 0.250 |
Why?
| Aged, 80 and over | 6 | 2015 | 3429 | 0.240 |
Why?
| Peptide Fragments | 4 | 2014 | 242 | 0.240 |
Why?
| Chromatography, High Pressure Liquid | 1 | 2004 | 377 | 0.230 |
Why?
| Kidney Medulla | 1 | 2002 | 18 | 0.220 |
Why?
| Glutamyl Aminopeptidase | 4 | 2017 | 4 | 0.220 |
Why?
| Antibodies, Anti-Idiotypic | 1 | 2022 | 30 | 0.210 |
Why?
| Antibodies, Neutralizing | 1 | 2022 | 75 | 0.210 |
Why?
| Urinalysis | 2 | 2013 | 50 | 0.210 |
Why?
| Medicine | 1 | 2022 | 58 | 0.210 |
Why?
| Receptor, Angiotensin, Type 1 | 1 | 2021 | 60 | 0.200 |
Why?
| Blood Platelets | 1 | 2023 | 269 | 0.200 |
Why?
| Models, Biological | 2 | 2016 | 823 | 0.190 |
Why?
| Lupus Erythematosus, Systemic | 1 | 2020 | 76 | 0.180 |
Why?
| Thrombosis | 1 | 2023 | 243 | 0.180 |
Why?
| Vaccination | 1 | 2022 | 293 | 0.180 |
Why?
| Students, Medical | 1 | 2022 | 173 | 0.180 |
Why?
| Adult | 10 | 2019 | 14182 | 0.180 |
Why?
| Kidney Tubules, Collecting | 2 | 2011 | 11 | 0.170 |
Why?
| Sphingolipids | 1 | 2019 | 14 | 0.170 |
Why?
| Permeability | 1 | 2019 | 87 | 0.170 |
Why?
| Membrane Proteins | 2 | 2023 | 389 | 0.160 |
Why?
| Cryopreservation | 1 | 2017 | 31 | 0.160 |
Why?
| Mesangial Cells | 2 | 2015 | 5 | 0.150 |
Why?
| Host-Pathogen Interactions | 1 | 2019 | 143 | 0.150 |
Why?
| Vancomycin | 1 | 2018 | 88 | 0.150 |
Why?
| User-Computer Interface | 3 | 2008 | 93 | 0.150 |
Why?
| Algorithms | 3 | 2016 | 697 | 0.150 |
Why?
| Receptors, Virus | 2 | 2015 | 30 | 0.150 |
Why?
| Intestinal Mucosa | 1 | 2019 | 259 | 0.150 |
Why?
| Enzyme-Linked Immunosorbent Assay | 2 | 2015 | 314 | 0.150 |
Why?
| Chromatography, Liquid | 3 | 2013 | 243 | 0.150 |
Why?
| Mitochondrial Proteins | 1 | 2017 | 121 | 0.150 |
Why?
| Diabetes Mellitus, Type 1 | 1 | 2019 | 202 | 0.140 |
Why?
| Database Management Systems | 2 | 2008 | 28 | 0.140 |
Why?
| Area Under Curve | 2 | 2013 | 205 | 0.140 |
Why?
| Blood Urea Nitrogen | 2 | 2020 | 51 | 0.140 |
Why?
| Heart Ventricles | 2 | 2010 | 271 | 0.140 |
Why?
| ROC Curve | 2 | 2013 | 259 | 0.140 |
Why?
| South Carolina | 1 | 2015 | 42 | 0.140 |
Why?
| Renin | 2 | 2013 | 23 | 0.140 |
Why?
| Kidney Function Tests | 1 | 2015 | 59 | 0.140 |
Why?
| Glycosphingolipids | 1 | 2015 | 3 | 0.130 |
Why?
| Neuromuscular Depolarizing Agents | 1 | 2015 | 3 | 0.130 |
Why?
| Kidney Transplantation | 1 | 2017 | 188 | 0.130 |
Why?
| Mitochondrial Proton-Translocating ATPases | 1 | 2015 | 6 | 0.130 |
Why?
| Dietary Supplements | 1 | 2019 | 449 | 0.130 |
Why?
| Peptide Mapping | 3 | 2003 | 22 | 0.130 |
Why?
| Diabetes Mellitus, Experimental | 2 | 2015 | 140 | 0.130 |
Why?
| Apolipoproteins E | 1 | 2015 | 62 | 0.130 |
Why?
| Neurodegenerative Diseases | 1 | 2015 | 83 | 0.130 |
Why?
| Regression Analysis | 1 | 2015 | 445 | 0.130 |
Why?
| Clinical Competence | 1 | 2018 | 446 | 0.120 |
Why?
| Risk Factors | 4 | 2021 | 3930 | 0.120 |
Why?
| Platelet Count | 2 | 2024 | 77 | 0.120 |
Why?
| Haptoglobins | 1 | 2013 | 4 | 0.120 |
Why?
| Mice | 8 | 2020 | 6413 | 0.120 |
Why?
| Thioredoxins | 1 | 2013 | 30 | 0.110 |
Why?
| Angiotensins | 1 | 2013 | 12 | 0.110 |
Why?
| Exercise Test | 1 | 2013 | 151 | 0.110 |
Why?
| Amino Acid Sequence | 3 | 2003 | 767 | 0.110 |
Why?
| Infusions, Intravenous | 2 | 2011 | 231 | 0.110 |
Why?
| Suramin | 1 | 2012 | 14 | 0.110 |
Why?
| Molecular Sequence Data | 3 | 2003 | 980 | 0.110 |
Why?
| Metabolic Networks and Pathways | 1 | 2013 | 104 | 0.110 |
Why?
| Blotting, Western | 3 | 2017 | 683 | 0.100 |
Why?
| Radiation-Protective Agents | 1 | 2013 | 116 | 0.100 |
Why?
| Receptors, Phospholipase A2 | 2 | 2023 | 20 | 0.100 |
Why?
| Anti-Bacterial Agents | 1 | 2018 | 820 | 0.100 |
Why?
| Time Factors | 3 | 2013 | 3212 | 0.100 |
Why?
| Intensive Care Units | 1 | 2013 | 231 | 0.100 |
Why?
| Kidney Tubules, Proximal | 2 | 2015 | 119 | 0.100 |
Why?
| Phosphatidylethanolamine Binding Protein | 1 | 2011 | 1 | 0.100 |
Why?
| Chemistry, Pharmaceutical | 1 | 2011 | 39 | 0.100 |
Why?
| Bone Marrow | 1 | 2013 | 411 | 0.100 |
Why?
| Neprilysin | 4 | 2013 | 16 | 0.100 |
Why?
| Mechanotransduction, Cellular | 1 | 2011 | 35 | 0.100 |
Why?
| Mitochondria | 1 | 2015 | 489 | 0.100 |
Why?
| Retrospective Studies | 4 | 2015 | 6432 | 0.100 |
Why?
| Nephrosis, Lipoid | 1 | 2010 | 7 | 0.090 |
Why?
| Retinol-Binding Proteins, Plasma | 1 | 2010 | 3 | 0.090 |
Why?
| Serum Albumin | 1 | 2010 | 62 | 0.090 |
Why?
| Neoplasms | 1 | 2020 | 1315 | 0.090 |
Why?
| Endothelial Cells | 1 | 2012 | 294 | 0.090 |
Why?
| Burkholderia cepacia complex | 1 | 2008 | 2 | 0.090 |
Why?
| Epithelial Cells | 1 | 2011 | 255 | 0.090 |
Why?
| Lamin Type A | 1 | 2008 | 2 | 0.090 |
Why?
| Tropomyosin | 1 | 2008 | 6 | 0.090 |
Why?
| Nickel | 1 | 2008 | 13 | 0.090 |
Why?
| Vimentin | 1 | 2008 | 33 | 0.080 |
Why?
| Information Storage and Retrieval | 2 | 2008 | 64 | 0.080 |
Why?
| Risk Assessment | 1 | 2013 | 1361 | 0.080 |
Why?
| Hematopoietic Stem Cell Transplantation | 1 | 2013 | 573 | 0.080 |
Why?
| Protein Array Analysis | 2 | 2008 | 28 | 0.080 |
Why?
| Loop of Henle | 1 | 2006 | 11 | 0.070 |
Why?
| Nephrolithiasis | 1 | 2006 | 4 | 0.070 |
Why?
| Diabetes Mellitus, Type 2 | 1 | 2013 | 481 | 0.070 |
Why?
| Kidney Tubules, Distal | 1 | 2006 | 17 | 0.070 |
Why?
| Models, Theoretical | 2 | 2005 | 184 | 0.070 |
Why?
| Gene Expression Regulation, Bacterial | 1 | 2008 | 244 | 0.070 |
Why?
| Cluster Analysis | 1 | 2007 | 249 | 0.070 |
Why?
| Internet | 2 | 2008 | 275 | 0.070 |
Why?
| Diagnostic Techniques, Urological | 1 | 2005 | 1 | 0.070 |
Why?
| Diagnosis, Differential | 1 | 2010 | 1136 | 0.070 |
Why?
| Cell Line | 3 | 2015 | 1153 | 0.070 |
Why?
| United States | 2 | 2013 | 5200 | 0.070 |
Why?
| Chick Embryo | 1 | 2005 | 79 | 0.070 |
Why?
| Hospitalization | 1 | 2010 | 705 | 0.070 |
Why?
| Treatment Outcome | 4 | 2023 | 5604 | 0.070 |
Why?
| Dialysis Solutions | 1 | 2004 | 3 | 0.060 |
Why?
| Databases, Protein | 1 | 2005 | 29 | 0.060 |
Why?
| Renal Dialysis | 1 | 2006 | 192 | 0.060 |
Why?
| Hemofiltration | 1 | 2004 | 7 | 0.060 |
Why?
| Kidney Neoplasms | 1 | 2006 | 196 | 0.060 |
Why?
| Protein Biosynthesis | 1 | 2006 | 273 | 0.060 |
Why?
| Albuminuria | 2 | 2015 | 42 | 0.060 |
Why?
| Terminology as Topic | 1 | 2004 | 72 | 0.060 |
Why?
| Antigen-Antibody Complex | 1 | 2023 | 39 | 0.060 |
Why?
| Platelet Aggregation | 1 | 2023 | 82 | 0.060 |
Why?
| Antibodies | 1 | 2003 | 178 | 0.050 |
Why?
| Adenosine | 1 | 2023 | 71 | 0.050 |
Why?
| Chi-Square Distribution | 2 | 2013 | 318 | 0.050 |
Why?
| Kallikreins | 1 | 2002 | 22 | 0.050 |
Why?
| Ticlopidine | 1 | 2023 | 57 | 0.050 |
Why?
| Actins | 1 | 2003 | 132 | 0.050 |
Why?
| Apolipoproteins | 1 | 2021 | 15 | 0.050 |
Why?
| Biopsy | 2 | 2018 | 692 | 0.050 |
Why?
| Glomerular Basement Membrane | 1 | 2021 | 12 | 0.050 |
Why?
| Protein Processing, Post-Translational | 1 | 2003 | 183 | 0.050 |
Why?
| Receptors, Transforming Growth Factor beta | 1 | 2021 | 26 | 0.050 |
Why?
| Cohort Studies | 2 | 2018 | 1543 | 0.050 |
Why?
| Mice, Knockout | 2 | 2017 | 926 | 0.050 |
Why?
| Career Choice | 1 | 2022 | 116 | 0.050 |
Why?
| Platelet Aggregation Inhibitors | 1 | 2023 | 180 | 0.050 |
Why?
| Proteoglycans | 1 | 2021 | 96 | 0.050 |
Why?
| Neural Cell Adhesion Molecules | 1 | 2020 | 13 | 0.050 |
Why?
| Thrombospondins | 1 | 2020 | 8 | 0.050 |
Why?
| Calcium-Binding Proteins | 1 | 2020 | 61 | 0.050 |
Why?
| Autoantigens | 1 | 2020 | 64 | 0.050 |
Why?
| Logistic Models | 2 | 2013 | 990 | 0.050 |
Why?
| Genotype | 1 | 2021 | 599 | 0.050 |
Why?
| Case-Control Studies | 1 | 2023 | 1228 | 0.050 |
Why?
| Young Adult | 3 | 2019 | 4308 | 0.050 |
Why?
| Disease Models, Animal | 2 | 2020 | 1639 | 0.050 |
Why?
| Glycosylation | 1 | 2019 | 112 | 0.040 |
Why?
| Cell Proliferation | 2 | 2015 | 1096 | 0.040 |
Why?
| Colorimetry | 1 | 2018 | 12 | 0.040 |
Why?
| Mice, Inbred C57BL | 2 | 2015 | 1999 | 0.040 |
Why?
| Inflammation | 1 | 2023 | 674 | 0.040 |
Why?
| Rats, Inbred Lew | 1 | 2017 | 67 | 0.040 |
Why?
| Manikins | 1 | 2018 | 40 | 0.040 |
Why?
| Cadaver | 1 | 2018 | 113 | 0.040 |
Why?
| Self Efficacy | 1 | 2018 | 137 | 0.040 |
Why?
| Ultrasonography, Interventional | 1 | 2018 | 146 | 0.040 |
Why?
| Fellowships and Scholarships | 1 | 2018 | 117 | 0.040 |
Why?
| Disease Susceptibility | 1 | 2017 | 95 | 0.040 |
Why?
| Antibody Specificity | 1 | 2015 | 48 | 0.030 |
Why?
| Lactosylceramides | 1 | 2015 | 2 | 0.030 |
Why?
| Cross Reactions | 1 | 2015 | 56 | 0.030 |
Why?
| Cells, Cultured | 2 | 2012 | 1737 | 0.030 |
Why?
| Oncogene Protein v-akt | 1 | 2015 | 11 | 0.030 |
Why?
| Smad3 Protein | 1 | 2015 | 9 | 0.030 |
Why?
| Albumins | 1 | 2015 | 38 | 0.030 |
Why?
| Information Dissemination | 2 | 2008 | 104 | 0.030 |
Why?
| Uromodulin | 1 | 2015 | 5 | 0.030 |
Why?
| Tissue Inhibitor of Metalloproteinase-2 | 1 | 2015 | 12 | 0.030 |
Why?
| Insulin-Like Growth Factor Binding Proteins | 1 | 2015 | 27 | 0.030 |
Why?
| Lipocalins | 1 | 2015 | 14 | 0.030 |
Why?
| Acute-Phase Proteins | 1 | 2015 | 25 | 0.030 |
Why?
| Feasibility Studies | 1 | 2016 | 398 | 0.030 |
Why?
| Eosinophils | 1 | 2015 | 36 | 0.030 |
Why?
| Radioligand Assay | 1 | 2014 | 49 | 0.030 |
Why?
| Neurotoxicity Syndromes | 1 | 2015 | 52 | 0.030 |
Why?
| Child | 2 | 2022 | 7337 | 0.030 |
Why?
| Injections, Intravenous | 1 | 2014 | 148 | 0.030 |
Why?
| Treatment Failure | 1 | 2014 | 139 | 0.030 |
Why?
| Nephrectomy | 1 | 2014 | 93 | 0.030 |
Why?
| Proto-Oncogene Proteins | 1 | 2015 | 169 | 0.030 |
Why?
| HEK293 Cells | 1 | 2014 | 245 | 0.030 |
Why?
| Mice, Congenic | 1 | 2013 | 8 | 0.030 |
Why?
| Antigens, CD | 1 | 2015 | 242 | 0.030 |
Why?
| Colony-Forming Units Assay | 1 | 2013 | 31 | 0.030 |
Why?
| Stem Cell Niche | 1 | 2013 | 10 | 0.030 |
Why?
| Extracellular Fluid | 1 | 2013 | 19 | 0.030 |
Why?
| Drug Administration Schedule | 1 | 2014 | 401 | 0.030 |
Why?
| Benzylamines | 1 | 2013 | 18 | 0.030 |
Why?
| Heterocyclic Compounds | 1 | 2013 | 30 | 0.030 |
Why?
| Cellular Microenvironment | 1 | 2013 | 27 | 0.030 |
Why?
| Adolescent | 2 | 2019 | 6885 | 0.030 |
Why?
| Health Knowledge, Attitudes, Practice | 1 | 2018 | 541 | 0.030 |
Why?
| Hematopoiesis | 1 | 2013 | 80 | 0.030 |
Why?
| Systems Biology | 1 | 2013 | 33 | 0.030 |
Why?
| Bone Marrow Cells | 1 | 2013 | 233 | 0.030 |
Why?
| Bayes Theorem | 1 | 2013 | 123 | 0.030 |
Why?
| Carboxypeptidases | 1 | 2012 | 7 | 0.030 |
Why?
| Intercellular Adhesion Molecule-1 | 1 | 2012 | 75 | 0.030 |
Why?
| Transforming Growth Factor beta1 | 1 | 2012 | 66 | 0.030 |
Why?
| Kaplan-Meier Estimate | 1 | 2013 | 514 | 0.030 |
Why?
| Risk | 1 | 2012 | 343 | 0.030 |
Why?
| Multivariate Analysis | 1 | 2013 | 643 | 0.030 |
Why?
| Hematopoietic Stem Cells | 1 | 2013 | 215 | 0.030 |
Why?
| Random Allocation | 1 | 2012 | 312 | 0.030 |
Why?
| Up-Regulation | 1 | 2013 | 508 | 0.030 |
Why?
| Cilia | 1 | 2011 | 9 | 0.030 |
Why?
| Computational Biology | 2 | 2004 | 231 | 0.020 |
Why?
| Odds Ratio | 1 | 2013 | 604 | 0.020 |
Why?
| Blood Volume | 1 | 2011 | 69 | 0.020 |
Why?
| Protein Kinase C | 1 | 2011 | 65 | 0.020 |
Why?
| Rotation | 1 | 2011 | 76 | 0.020 |
Why?
| Hospital Mortality | 1 | 2013 | 465 | 0.020 |
Why?
| Extracellular Signal-Regulated MAP Kinases | 1 | 2011 | 101 | 0.020 |
Why?
| Pilot Projects | 1 | 2013 | 808 | 0.020 |
Why?
| Urinary Tract | 1 | 2010 | 26 | 0.020 |
Why?
| NF-kappa B | 1 | 2012 | 335 | 0.020 |
Why?
| Tumor Suppressor Proteins | 1 | 2011 | 141 | 0.020 |
Why?
| Kidney Failure, Chronic | 1 | 2012 | 231 | 0.020 |
Why?
| Remission Induction | 1 | 2010 | 221 | 0.020 |
Why?
| Dose-Response Relationship, Drug | 1 | 2013 | 1476 | 0.020 |
Why?
| Analysis of Variance | 1 | 2011 | 635 | 0.020 |
Why?
| Phosphorylation | 1 | 2011 | 614 | 0.020 |
Why?
| Protein Kinase Inhibitors | 1 | 2011 | 216 | 0.020 |
Why?
| Mice, Transgenic | 1 | 2011 | 656 | 0.020 |
Why?
| Isoantibodies | 1 | 2008 | 31 | 0.020 |
Why?
| Hydrogen-Ion Concentration | 1 | 2008 | 194 | 0.020 |
Why?
| Protein Isoforms | 1 | 2008 | 124 | 0.020 |
Why?
| Hypermedia | 1 | 2008 | 1 | 0.020 |
Why?
| Recurrence | 1 | 2010 | 690 | 0.020 |
Why?
| Rats, Wistar | 1 | 2008 | 237 | 0.020 |
Why?
| Knowledge Bases | 1 | 2008 | 10 | 0.020 |
Why?
| Signal Transduction | 1 | 2015 | 1753 | 0.020 |
Why?
| Cell Differentiation | 1 | 2011 | 720 | 0.020 |
Why?
| Reference Values | 1 | 2008 | 354 | 0.020 |
Why?
| Prospective Studies | 1 | 2013 | 2604 | 0.020 |
Why?
| Protease Inhibitors | 1 | 2007 | 64 | 0.020 |
Why?
| Research Design | 1 | 2008 | 374 | 0.020 |
Why?
| Follow-Up Studies | 1 | 2011 | 2387 | 0.020 |
Why?
| Programming Languages | 1 | 2004 | 7 | 0.020 |
Why?
| Computer Graphics | 1 | 2004 | 11 | 0.020 |
Why?
| Reference Standards | 1 | 2004 | 63 | 0.020 |
Why?
| Acetone | 1 | 2002 | 6 | 0.010 |
Why?
| Tryptases | 1 | 2002 | 4 | 0.010 |
Why?
| Ultracentrifugation | 1 | 2002 | 8 | 0.010 |
Why?
| Chemical Precipitation | 1 | 2002 | 4 | 0.010 |
Why?
| Solvents | 1 | 2002 | 35 | 0.010 |
Why?
| Serine Endopeptidases | 1 | 2002 | 57 | 0.010 |
Why?
| Staining and Labeling | 1 | 2002 | 106 | 0.010 |
Why?
| Software | 1 | 2004 | 296 | 0.010 |
Why?
| Child, Preschool | 1 | 2010 | 4146 | 0.010 |
Why?
| Gene Expression Profiling | 1 | 2005 | 1138 | 0.010 |
Why?
| Blood Pressure | 1 | 2002 | 586 | 0.010 |
Why?
|
|
Arthur's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|